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Abstract
Background: Sidestream dark field (SDF) imaging has been used to demonstrate microcirculatory abnormalities in
a variety of critical illnesses. The microcirculation is also affected by advancing age and chronic comorbidities.
However, the effect of these conditions on SDF microcirculatory parameters has not been well described.
Methods: SDF images were obtained from five groups of 20 participants: healthy volunteers under the age of 25,
healthy volunteers over the age of 55, and clinic patients over the age of 55 with one of diabetes mellitus, cirrhosis
and stage 5 chronic kidney disease. Microcirculatory parameters between the groups were then compared for
significance using analysis of variance for parametric and the Kruskal-Wallis test for non-parametric data.
Results: Median microvascular flow index was 2.85 (interquartile range 2.75 to 3.0) for participants aged <25, 2.81
(2.66 to 2.97) for those aged >55, 2.88 (2.75 to 3.0) for those with diabetes mellitus, 3.0 (2.83 to 3.0) for those with
cirrhosis and 3.0 (2.78 to 3.0) for those with chronic kidney disease (P for difference between groups = 0.14).
Similarly, there were no significant differences in the proportion of perfused vessels and perfused vessel density
between the groups.
Conclusions: Older age, diabetes, and chronic kidney and liver disease need not be considered confounding
factors for comparison of SDF microcirculatory parameters in the critically ill.
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Background
Critical illness is often accompanied by abnormalities of the
microcirculation [1]. Persistent alterations such as hetero-
geneity of flow and microvascular shunting can lead to
tissue hypoxia and are associated with organ failure and
death [2-4], while impaired microvascular flow in the
perioperative period is associated with the development of
complications [5]. Improving systemic measures of perfu-
sion can be accompanied by improved microcirculatory
parameters [6] but the relationship between the two is not
always straightforward [7,8], including during vasopressor
treatment [9,10]. Monitoring the microcirculation may thus
help evaluate an individual patient’s tissue perfusion [7,11].
The novel techniques of orthogonal polarisation spec-
tral (OPS) imaging [12], and more recently sidestream
dark field (SDF) imaging [13] allow imaging of the micro-
circulation in vivo in a way that was previously technically
difficult. Research using these techniques has helped char-
acterise the sublingual microcirculation in various acute
diseases, and describe the changes in microcirculatory
parameters following acute physiological changes or admin-
istration of pharmacological therapies. However, the influ-
ence of existing chronic conditions on microcirculatory
assessments made using SDF and OPS imaging has not
been well studied. Advancing age, diabetes mellitus, cirrho-
sis, and end-stage renal failure are commonly found in
critically ill perioperative patients [14,15]. All have well
recognised associations with an abnormal microvasculature,
and altered microvascular flow has been demonstrated
using other techniques [16-19]. In order to interpret
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current and future clinical studies of the microcirculation
using SDF and OPS imaging, it is essential to determine
whether stable patients with advanced age and these
chronic diseases exhibit changes in sublingual microvascu-
lature when assessed using these techniques. The objective
of this study was to help provide this understanding by
evaluating sublingual microvascular flow using SDF
imaging in healthy older volunteers and in patients with
diabetes, cirrhosis and chronic kidney disease (CKD).
Methods
Study design
This was a single centre, observational study based at a
university hospital, and was approved by East London
and the City Research Ethics Committee (ref. 09/H0704/3).
Patients aged over 55 years with one of either diabetes
(diagnosed >2 years), cirrhosis (confirmed by liver biopsy or
expert hepatology opinion) or CKD (stage 5 by estimated
glomerular filtration rate, but not on dialysis) were identi-
fied from amongst those attending diabetology, hepatology
or nephrology outpatient clinics. Healthy volunteers
aged either under 25 or over 55 years without medical
disease were identified from among hospital staff and their
relatives. All participants gave written informed consent.
Exclusion criteria were pregnancy, age 18 years and refusal
of consent.
Data collection
Sublingual microvascular flow was evaluated using
sidestream dark field imaging with a x5 objective lens
(Microscan, Microvision Medical, Amsterdam, Netherlands)
[20]. Image acquisition and subsequent blinded analysis was
performed according to published consensus criteria [21].
SDF images were obtained from at least three sublingual
areas. Microvascular flow index (MFI) was calculated after
dividing each image into four equal quadrants. Quantifica-
tion of flow was determined using an ordinal scale (0: no
flow, 1: intermittent flow, 2: sluggish flow, 3: normal flow)
for small (<20 μm) and large (>20 μm) vessels. MFI is the
average score of all quadrants for a given category of vessel
size. Vessel density was calculated by inserting a grid of
three equidistant horizontal and three equidistant vertical
lines over the image. Vessel density is equal to the number
of vessels crossing these lines divided by their total length.
Flow was then categorised as present, intermittent or absent
to calculate the proportion of perfused vessels (PPV) and
thus the perfused vessel density (PVD), an estimate of func-
tional capillary density (FCD). Analysis of the videos was
performed by a single, blinded observer (TR). Additional
data collected for all participants included age, weight, gen-
der, past medical history, current medications, pulse rate,
sublingual temperature, heart rate and blood pressure.
In diabetic patients the most recent HbA1c percent-
age result was recorded. In patients with cirrhosis the
current Child-Turcotte-Pugh score was recorded. In
patients with renal disease, the creatinine clearance was
estimated from plasma creatinine using the four-variable
modified diet in renal disease method [22].
Statistical analysis
Data from a previous study, performed locally, demon-
strated a difference in MFI of 0.3 prior to major abdominal
surgery in those patients who went on to develop compli-
cations after surgery compared to those who did not [5].
Assuming a type I error rate of 5% (two-tailed) and a type
II error rate of 10% using this previous data, 20 patients
would be required in each group to detect a difference in
MFI of 0.26 (SD ± 0.25). We therefore aimed to recruit 20
participants in each group. Parametric data are presented
as mean (standard deviation, SD) and non-parametric data
are presented as median (interquartile range, IQR).
Variable distributions were assessed for normality using
the Kolmogorov-Smirnov test. The primary outcome
measure of this study was a difference in small vessel MFI
between the groups. Secondary outcome measures were
differences in PPV and PVD for small vessels. Differences
between groups were tested using analysis of variance
(ANOVA) for parametric data and the Kruskal-Wallis test
for non-parametric data. Significance was set at P <0.05.
Statistical calculations were performed in SPSS (SPSS Inc,
Chicago, IL, USA).
Results
One hundred participants were recruited between
September 2010 and July 2011. Adequate video footage
was obtained in 98 participants (20 aged <25 years, 20
Table 1 Baseline participant data
Age <25 years Age >55 years Diabetes mellitus Cirrhosis Chronic kidney disease
Male 10 (50%) 9 (45%) 10 (50%) 12 (67%) 14 (70)
Age (years) 24 (23–25) 61 (60–65) 64 (62–72) 60 (57–66) 71 (64–74)
Body mass index (kg/m2) 21.9 (20.9–24.9) 24.7 (23.0–29.0) 29.4 (24.8–32.9) 24.8 (23.7–26.9) 28.0 (24.6–33.3)
Sublingual temperature (°C) 36.5 (36.3–37.0) 36.4 (36.0–36.7) 36.2 (36.0–36.5) 36.6 (36.2–37.2) 36.5 (36.5–36.8)
Mean arterial pressure (mmHg) 93 (91–96) 100 (93–109) 92 (88–102) 98 (89–106) 98 (89–106)
Heart rate (bpm) 72 (63–82) 75 (65–83) 72 (62–86) 74 (64–92) 70 (65–80)
Data presented as n (%) or median (IQR). n = 20 for all groups except cirrhosis where n = 18.
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aged >55 years, 20 with diabetes, 18 with cirrhosis, and 20
with stage 5 CKD). Participant characteristics and baseline
clinical data are displayed in Table 1. All the healthy young
participants had no medical problems, were non-smokers
and declared no regular medication use. Two healthy
older participants took medication for hypothyroidism
(normal thyroid function tests), two were smokers, two
took statins and two took antihypertensive medication, all
for primary prevention of cardiovascular disease. All dia-
betic patients suffered from type 2 diabetes, nine took in-
sulin and 15 took antihypertensive medication. The mean
glycated haemoglobin (HbA1c) for patients with diabetes
was 8.8% (SD 1.7%). For participants with cirrhosis, three
took propranolol for variceal bleeding prophylaxis, and
eight took other antihypertensive medication. The cause
of cirrhosis was viral in 11 cases, alcohol-related in five
cases, medication-related in one case and cryptogenic in
one case. Seventeen patients were Child-Pugh-Turcotte
score A and one was score B. For patients with stage 5
CKD, this was due to intrinsic renal disease in seven cases,
polycystic kidney disease in one case, reflux nephropathy
in one case, drug toxicity in one case, and hypertension in
ten cases. All were taking antihypertensive medication.
The mean estimated glomerular filtration rate was
11.5 ml/min (SD 2.9).
A median of 3 (IQR 2 to 4) clips were analysed for
each patient. For small vessels (<20 μm), there were no
statistically significant differences in MFI, PPV and PVD
between the groups (Figure 1 and Table 2). This finding
was repeated in a secondary analysis that excluded the
two hypertensive participants from the healthy >55
group. Baseline sublingual large vessel (>20 μm) MFI
was median 3.0 (IQR 2.9 to 3.0) and PPV was median
1.0 (IQR 0.97 to 1.0), suggesting good quality image
capture unaffected by pressure artefact.
Discussion
The principal finding of this study was that sublingual
SDF imaging does not demonstrate statistically signifi-
cant differences in MFI, PPV and PVD between healthy
young volunteers, healthy older volunteers, and patients
with diabetes, cirrhosis and end-stage renal failure. MFI
was lower in older volunteers and higher in those with
cirrhosis and renal failure, and PVD was higher in
patients with diabetes, cirrhosis and renal failure. However,
none of these trends reached significance.
There is little doubt that age, diabetes, cirrhosis and
renal disease do cause alterations to the microvascula-
ture. Diabetes, particularly type 2 diabetes, is associated
with increased capillary density. This has been recently
demonstrated using SDF imaging of the labial microcir-
culation [23]. Our results showed a trend towards an
increased PVD that was not statistically significant. Simi-
larly, our results indicated a non-significant trend
towards higher PVD and MFI values in cirrhotic and
CKD patients. In cirrhosis, vasodilatory mediators
promote arteriovenous shunting, eventually leading to
the development of a hyperdynamic circulation. Cir-
rhotic patients show an exaggerated post-ischaemic
hyperaemia response, which has been interpreted as evi-
dence that the peripheral microvasculature is pre-
disposed to vasodilatation [24]. Sheikh and colleagues
recorded seemingly low MFI values in their comparison
of SDF analysis of compensated, decompensated and
septic cirrhotic patients [25], but as their study did not
include any healthy patients, comparison with our own
results is not possible. Using nailfold microscopy, Thang
and colleagues found a trend towards reduced capillary
density in CKD stage 5 patients compared to controls,
although this did not reach significance [26]. Bemelmans
and colleagues compared MFI in dialysis patients before
and after dialysis [27]. The baseline MFI values they
Figure 1 Microvascular flow index for all participants.
Microvascular flow index (MFI). Data presented as median (IQR).
n = 20 for all groups except cirrhosis where n = 18.
Table 2 SDF microvascular flow parameters for all participants
Age <25 years Age >55 years Diabetes mellitus Cirrhosis Chronic kidney disease P value
MFI 2.85 (2.75–3.0) 2.81 (2.66–2.97) 2.88 (2.75–3.0) 3.0 (2.83–3.0) 3.0 (2.78–3.0) 0.14
PPV 0.92 (0.06) 0.88 (0.09) 0.92 (0.07) 0.89 (0.08) 0.91 (0.05) 0.46
PVD 8.04 (1.49) 8.02 (0.96) 9.17 (1.70) 8.51 (1.43) 8.38 (1.36) 0.08
PPV in %, PVD in mm-1. Data presented as mean (SD) or median (IQR). n = 20 for all groups except cirrhosis where n = 18. MFI, microvascular flow index; PPV,
proportion of perfused vessels; PVD, perfused vessel density.
Reynolds et al. Perioperative Medicine 2013, 2:7 Page 3 of 5
http://www.perioperativemedicinejournal.com/content/2/1/7
found are similar to those we report, but without a
control group in their study, comparison is not possible.
We found that microvascular flow as measured by
SDF parameters was not significantly different when
subjects were older or had comorbid diabetes, chronic
kidney disease or cirrhosis. It is possible that a much
larger study than ours may have identified differences
between these groups and young, healthy subjects
using SDF parameters. It is also possible that alterna-
tive techniques may have detected differences that
were not apparent using SDF imaging. However, our
aim was to identify important confounding effects in
the use of SDF parameters to assess for acute changes
in the microcirculation of critically ill patients.
Assessment of the microcirculation specifically using
SDF imaging has generated significant research inter-
est in perioperative medicine and critical care, in part
because this technique can be used in vivo with
minimal disruption to the subject and could potentially
form an important part of bedside clinical evaluation. In
calculating our sample size, we specified an effect size
equal to a 0.26 difference in MFI, on the basis that effect
sizes of this magnitude have been seen in previous
studies of critically ill patients. Thus we believe our
results show that no such confounding effects need
be taken into account.
We cannot rule out the possibility that pre-existing
microvascular dysfunction not apparent on SDF imaging
may predispose patients with chronic diseases to SDF-
detectable microvascular flow alterations when they be-
come acutely unwell. Further research would be needed
to investigate the importance of any such effect.
Conclusions
Advancing age, diabetes mellitus, chronic kidney disease
and cirrhosis do not appear to cause changes in sublingual
microvascular flow assessed by sidestream dark field
imaging in stable patients.
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